Alyteserin-2b

General Information


DRACP ID  DRACP02363

Peptide Name   Alyteserin-2b

Sequence  ILGAILPLVSGLLSNKL

Sequence Length  17

UniProt ID  Not available

PubChem CID  Not available

Origin  Alytes obstetricans

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma LC50>100 µM CellTiter-Glo Luminescent Cell Viability assay 24 h 1

Hemolytic Activity  Human erythrocytes: 50% Hemolysis=115 µM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02363

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C81H145N19O21

Absent amino acids  CDEFHMQRTWY

Common amino acids  L

Mass  200675

Pl  9.7

Basic residues  1

Acidic residues  0

Hydrophobic residues  10

Net charge  1

Boman Index  2810

Hydrophobicity  155.29

Aliphatic Index  206.47

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 22392897

Title  Analogues of the frog skin peptide alyteserin-2a with enhanced antimicrobial activities against Gram-negative bacteria

Doi 10.1002/psc.2397

Year  2012

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_4393

DRACP is developed by Dr.Zheng's team.